Germany's Donation of 100,000 Vaccines Fails to Curb the Spread of the Epidemic in Africa: What Happens to the 117,000 Doses in Stock?
The German government has officially announced an important donation of 100,000 doses of mpox vaccine to global health organizations. This initiative aims to provide financial assistance to the World Health Organization through multiple channels to help the African region contain the further spread of the epidemic. The German government will tap its GavI stockpile of about 117,000 doses of Jynneos vaccine, which it procured in 2022 and which has been kept by the military. A spokesperson for the German Defense Ministry made it clear that they will maintain the minimum stocks necessary to ensure the health and safety of key personnel. At the same time, they will carefully consider reordering vaccines based on the actual situation.
The World Health Organization has classified the Mpox outbreak as a global public health emergency. The outbreak has now spread from the Democratic Republic of Congo to neighbouring countries. A spokesman for the German Foreign Ministry said the government was actively looking for quick ways to deliver the vaccine to hard-hit countries, in particular the Democratic Republic of Congo and neighboring countries. This action fully demonstrates the German government's strong support for international public health and humanitarian assistance.
Looking for chemical products? Let suppliers reach out to you!
2026-07-12
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
IPEC Updates Excipient Qualification Guidance
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
Novo Nordisk Launches Wegovy in South Africa One in Two Adults Faces Obesity as GLP-1 Drug Competition Heats Up
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
BASF Raises API and Excipient Prices
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
Recommend Reading
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
The FDA Officially Blesses AI for Liver Drug Development
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
This week, caustic soda prices showed a weak trend (12.8-12.12)
-
El Salvador Faces 2.9 Million in Food Insecurity as Global Hunger Rate Dips to 8.2 Percent
-
This week, the TDI market in China showed a strong upward trend (12.8-12.12)
-
Bayer Files Icafolin Herbicide in Four Major Markets Sales Forecast to Hit 750 Million Euros
-
Raw Material Prices Continue to Rise, Anhydrous Hydrogen Fluoride Market Remains Firm in China (12.8-12.12)